← Back to Solu website | 🔍 Search ****these pages with the button in the top right ****↑ ****
Solu is on a mission to combat antibiotic resistance by making DNA analysis accessible, enabling better and faster diagnostics and treatments to a major health threat.
Our first product is a DNA analysis platform that can identify antibiotic resistance from genome sequencing data in a few minutes (95% faster). But we’re not stopping there – we’re planning to consolidate all genome data to the world’s fastest and smartest platform.
Our product is already used by top researchers like Stanford University. We’ve raised a pre-seed round led by Lifeline Ventures, and we’re backed by a broad network of scientific advisors and angel investors.
Read more of our company, product and mission:
Solu – Epidemic Prevention with Genomics.